1.New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3.
Peipei CHEN ; Yunshu WANG ; Huaiping TANG ; Chao ZHOU ; Zhuo LIU ; Shenghan GAO ; Tingting WANG ; Yun XU ; Sen-Lin JI
Journal of Pharmaceutical Analysis 2025;15(1):101069-101069
The NOD-like receptor protein 3 (NLRP3) inflammasome is essential in innate immune-mediated inflammation, with its overactivation implicated in various autoinflammatory, metabolic, and neurodegenerative diseases. Pharmacological inhibition of NLRP3 offers a promising treatment strategy for inflammatory conditions, although no medications targeting the NLRP3 inflammasome are currently available. This study demonstrates that clioquinol (CQ), a clinical drug with chelating properties, effectively inhibits NLRP3 activation, resulting in reduced cytokine secretion and cell pyroptosis in both human and mouse macrophages, with a half maximal inhibitory concentration (IC50) of 0.478 μM. Additionally, CQ mitigates experimental acute peritonitis, gouty arthritis, sepsis, and colitis by lowering serum levels of interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α). Mechanistically, CQ covalently binds to Arginine 335 (R335) in the NACHT domain, inhibiting NLRP3 inflammasome assembly and blocking the interaction between NLRP3 and its component protein. Collectively, this study identifies CQ as an effective natural NLRP3 inhibitor and a potential therapeutic agent for NLRP3-driven diseases.
2.Correlation study between CT features of clear cell renal cell carcinoma whose diameter ≥7 cm and its Fuhrman grade
Jun SHU ; Xiaoli MENG ; Ruwu YANG ; Yongqiang TANG ; Huaiping YUAN ; Hong YIN
Journal of Practical Radiology 2018;34(5):721-724
Objective To investigate the application value of CT features of clear cell renal cell carcinoma (CCRCC) whose diameter ≥ 7 cm in predicting its Fuhrman grade.Methods 53 patients with CCRCC confirmed by surgery and pathology were analyzed retrospectively,including 19 patients regarded as a low-grade (Grade Ⅰ and Grade Ⅱ) group,and other 34 ones as a high-grade (Grade Ⅲ and Grade Ⅳ) group.The CT features including necrosis,renal sinus involvement,shape,renal vein invasion,lymphnode metastasis,pseudo-capsule,blood vessels around the tumor and the boundary between the tumor and the perirenal fat were analyzed,and the differences in those CT features between two groups were analyzed with chi-square or Fisher exact test.Results The incidence of fuzzy boundary between the tumor and the perirenal fat in the high-grade group was higher than that in the low-grade group (x2 =6.129,P =0.013),however,the differences of the rest CT features between two groups were not statistically significant (P>0.05).When the fuzzy boundary was used to predict the high-grade CCRCC,the sensitivity,specificity and accuracy was 61.8 %,73.7 % and 66.0 %,respectively.Conclusion When the diameter of the tumor ≥7 cm,only the fuzzy boundary between the tumor and the perirenal fat has certain value in predicting high-grade CCRCC.
3.Study on Applicability of Microbiological Examination Methods for Shegan Mixture in Chinese Pharmacopoeia 2015
Huaiping TIAN ; Ling WANG ; Yi DU ; Yuenian TANG
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(10):72-75
Objective To standardize the method of microbiological examination on Shegan Mixture in Chinese Pharmacopoeia 2015. Methods Chinese Pharmacopoeia 2015 was used. Microbial enumeration test and specified microorganisms test were used to verify Shegan Mixture. The samples were treated by membrane filtration. Six kinds of strains for microbiological counting and limiting bacteria were used to study applicability. Results Microbial counts of the five strains of the recovery ratio were between 0.5 to 2, and Escherichia coli tested by control bacteria was qualified. Conclusion The microbiological examination methods for Shegan Mixture can meet the requirements of Chinese Pharmacopoeia 2015.
4.Lamotrigine for absence seizures in children and adolescents:a systematic review
Huaiping TIAN ; Huimin GAO ; Jinlian ZHANG ; Yuenian TANG
Journal of Pharmaceutical Practice 2015;(3):263-268
Objective To assess the efficacy and safety of lamotrigine for absence seizures in children and adolescents . Methods Databases of PubMed ,the Cochrane Library ,EMbase ,CENTRAL ,VIP ,WanFang ,CBM and CNKI were electron-ically searched till August ,2014 for clinical trials on lamotrigine for absence seizures in children and adolescents .All literature were screened by two reviewers independently according to the inclusion and exclusion criteria .The data was extracted ,and the methodological quality was assessed .Then ,meta-analysis was performed using RevMan 5 .2 .Results Seven trials were in-cluded involving a total of 721 patients .The results of methodological qualities were two studies rated as A-class ,three studies rated as B-class and two studies rated as C-class .Meta-analysis results showed that the efficacy of lamotrigine monotherapy for absence seizure in children and adolescents was better than placebo ,but efficacy of lamotrigine was lower than valproic acid and ethosuximide .The adverse reaction rates of lamotrigine were with no significant difference compared with valproic acid and et-hosuximide .Conclusion Lamotrigine monotherapy was effective for absence seizures in children and adolescents and was well tolerated .Lamotrigine was a good choice for patients that are intolerable to valproic acid or ethosuximide .

Result Analysis
Print
Save
E-mail